SARS-CoV-2 Spike S1-specific IgG kinetic profiles following mRNA or vector-based vaccination in the general Dutch population show distinct kinetics.
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
van den Hoogen, Lotus LVerheul, Marije K
Vos, Eric R A
van Hagen, Cheyenne C E
van Boven, Michiel
Wong, Denise
Wijmenga-Monsuur, Alienke J
Smits, Gaby
Kuijer, Marjan
van Rooijen, Debbie
Bogaard-van Maurik, Marjan
Zutt, Ilse
van Vliet, Jeffrey
Wolf, Janine
van der Klis, Fiona R M
de Melker, Hester E
van Binnendijk, Robert S
den Hartog, Gerco
Type
ArticleLanguage
en
Metadata
Show full item recordTitle
SARS-CoV-2 Spike S1-specific IgG kinetic profiles following mRNA or vector-based vaccination in the general Dutch population show distinct kinetics.Published in
Scientific reports 2022;12(1):5935PMID
35396570ae974a485f413a2113503eed53cd6c53
10.1038/s41598-022-10020-6
Scopus Count
Collections
Related articles
- The Mucosal and Serological Immune Responses to the Novel Coronavirus (SARS-CoV-2) Vaccines.
- Authors: Chan RWY, Liu S, Cheung JY, Tsun JGS, Chan KC, Chan KYY, Fung GPG, Li AM, Lam HS
- Issue date: 2021
- Immunogenicity of a first dose of mRNA- or vector-based SARS-CoV-2 vaccination in dialysis patients: a multicenter prospective observational pilot study.
- Authors: Lesny P, Anderson M, Cloherty G, Stec M, Haase-Fielitz A, Haarhaus M, Santos C, Lucas C, Macario F, Haase M
- Issue date: 2021 Aug
- Differing kinetics of anti-spike protein IgGs and neutralizing antibodies against SARS-CoV-2 after Comirnaty (BNT162b2) immunization.
- Authors: Bonura F, De Grazia S, Bonura C, Sanfilippo GL, Giammanco GM, Amodio E, Ferraro D
- Issue date: 2022 May
- Neutralizing antibody titers six months after Comirnaty vaccination: kinetics and comparison with SARS-CoV-2 immunoassays.
- Authors: Padoan A, Cosma C, Bonfante F, Della Rocca F, Barbaro F, Santarossa C, Dall'Olmo L, Pagliari M, Bortolami A, Cattelan A, Cianci V, Basso D, Plebani M
- Issue date: 2022 Feb 23
- Immunogenicity of the BNT162b2 COVID-19 mRNA vaccine and early clinical outcomes in patients with haematological malignancies in Lithuania: a national prospective cohort study.
- Authors: Maneikis K, Šablauskas K, Ringelevičiūtė U, Vaitekėnaitė V, Čekauskienė R, Kryžauskaitė L, Naumovas D, Banys V, Pečeliūnas V, Beinortas T, Griškevičius L
- Issue date: 2021 Aug